Company Overview of Helix Therapeutics, Inc.
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis. The company was founded in 2006 and is based in New Haven, Connecticut.
150 Munson Street
25 Science Park
New Haven, CT 06511
Founded in 2006
Key Executives for Helix Therapeutics, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Helix Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.